ACOTEC-B (06669) announced that on December 1, 2025, the group received registration approval from China's National Medical Products Administration (NMPA) for its V-otter microcatheter.

The V-otter is indicated for use in percutaneous peripheral and coronary vascular interventions to deliver diagnostic, embolic, or therapeutic materials to target vascular sites. Designed specifically for transarterial chemoembolization (TACE) procedures, the microcatheter features a large-lumen design to effectively prevent intraoperative catheter occlusion.

The product offers three tip-shaping options—straight, 45° single curve, and multi-curve configurations—enabling clinicians to adapt to branch vessels at various angles based on clinical needs. This facilitates precise and stable access to target vessels, preparing the groundwork for subsequent procedures.

The company plans to initiate marketing activities in China at an appropriate time.